Analysts expect enGene Therapeutics Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 740,156.21 | 1.07 M | 9.86 M | 10.98 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 652,738.15 | 932,826.65 | 8.50 M | 9.55 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 696,447.18 | 1.00 M | 9.18 M | 10.27 M |
Analysts expect enGene Therapeutics Inc. to report earnings per share of -0.42 for Q3 26, against a range of -0.44 to -0.40. The most recent reported quarter, Q2 26, came in at -0.43, a 6.5% beat against the -0.46 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.32 | -0.35 | -0.48 | -0.51 | -0.57 | -0.73 | -0.44 | -0.43 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.35 | -0.42 | -0.32 | -0.50 | -0.51 | -0.51 | -0.51 | -0.43 | -0.40 | -0.34 | -0.27 | -0.25 | -0.36 | -0.40 | -0.21 | -0.17 | ||||||||||
| Low Estimate | -0.37 | -0.44 | -0.38 | -0.56 | -0.55 | -0.55 | -0.57 | -0.49 | -0.44 | -0.42 | -0.31 | -0.29 | -0.38 | -0.44 | -0.23 | -0.19 | ||||||||||
| Consensus Estimate | -0.36 | -0.43 | -0.35 | -0.53 | -0.53 | -0.53 | -0.54 | -0.46 | -0.42 | -0.38 | -0.29 | -0.27 | -0.37 | -0.42 | -0.22 | -0.18 |